Risk-Benefit Assessment of Opioids in Chronic Noncancer Pain

被引：0
|
作者：
Bernard Bannwarth
机构：
[1] Victor Segalen University,Department of Rheumatology, Pellegrin Hospital, and Laboratory of Therapeutics
[2] Hôpital Pellegrin,Service de Rhumatologie
来源：
Drug Safety | 1999年 / 21卷
关键词：
Morphine; Adis International Limited; Paracetamol; Neuropathic Pain; Tramadol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Opioids have been accepted as appropriate treatment for acute and cancer pain, but their role in the management of chronic nonmalignant pain is the subject of much debate, mainly due to concerns about waning efficacy, the potential for neuropsychological impairment and the development of drug addiction.
引用
收藏
页码：283 / 296
页数：13
相关论文
共 50 条
  • [21] Risk-Benefit Assessment of Foods
    Assuncao, R.
    Pires, S. M.
    Nauta, M.
    [J]. EFSA JOURNAL, 2019, 17
  • [22] Risk-benefit assessment of ivabradine in the treatment of chronic heart failure
    Urbanek, Irmina
    Kaczmarek, Krzysztof
    Cygankiewicz, Iwona
    Ptaszynski, Pawel
    [J]. DRUG HEALTHCARE AND PATIENT SAFETY, 2014, 6 : 47 - 54
  • [23] Opioids for persistent noncancer pain
    McCleane, Gary
    Smith, Howard S.
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2007, 91 (02) : 177 - +
  • [24] Opioids for noncancer pain in the elderly
    Schuler, M.
    Griessinger, N.
    [J]. SCHMERZ, 2015, 29 (04): : 380 - 401
  • [25] Opioids in chronic noncancer pain: More faces from the crowd
    Watson, C. Peter N.
    [J]. PAIN RESEARCH & MANAGEMENT, 2012, 17 (04): : 263 - 275
  • [26] Inconsistencies in the 2017 Canadian Guideline for Opioids for Chronic Noncancer Pain
    Weinberg, Erica L.
    Baer, Philip A.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2017, 189 (39) : E1233 - E1233
  • [27] Opioids for chronic noncancer pain: a new Canadian practice guideline
    Furlan, Andrea D.
    Reardon, Rhoda
    Weppler, Clarence
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2010, 182 (09) : 923 - 930
  • [28] Opioids for Chronic Noncancer Pain: Still No Evidence for Superiority of Sustained-Release Opioids
    Pedersen, L.
    Fredheim, O. M. S.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 (02) : 114 - 115
  • [29] Risk Assessment of Opioid Misuse in Italian Patients with Chronic Noncancer Pain
    Ferrari, Renata
    Duse, Genni
    Capraro, Michela
    Visentin, Andmarco
    [J]. PAIN RESEARCH AND TREATMENT, 2014, 2014
  • [30] A Risk-Benefit Assessment of Amifostine in Cytoprotection
    May Mabro
    Sandrine Faivre
    Eric Raymond
    [J]. Drug Safety, 1999, 21 : 367 - 387
12345